• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Analysis of essential regions for biological activities of the potent anti-HIV protein actinohivin that binds to high-mannose sugar chains of gp 120

Research Project

Project/Area Number 14572064
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Biological pharmacy
Research InstitutionKitasato University

Principal Investigator

INOKOSHI Junji  Kitasato University, School of Pharmaceutical Sciences, Assistant Professor, 薬学部, 講師 (30151640)

Co-Investigator(Kenkyū-buntansha) CHIBA Harumi  Kitasato University, School of Pharmaceutical Sciences, Research associate, 薬学部, 助手 (90276163)
Project Period (FY) 2002 – 2003
Project Status Completed (Fiscal Year 2003)
Budget Amount *help
¥2,200,000 (Direct Cost: ¥2,200,000)
Fiscal Year 2003: ¥700,000 (Direct Cost: ¥700,000)
Fiscal Year 2002: ¥1,500,000 (Direct Cost: ¥1,500,000)
KeywordsActinohivin / anti-HIV / recombinant protein / syncytium formation / production / actinomycete / Eschelichia coli / entry inhibitor / アクチノヒビン / 組換えたん白質 / 糖鎖結合モジュール / 高マンノース型糖鎖
Research Abstract

Actinohivin (AH) which is a novel anti-HIV protein isolated from the culture broth of Longispora albida gen. novo., sp. novo., consists of 114 amino acid residues. The proposes of this project were to clarify the structure-activity relationship of AH and to obtain the basic evidence for the creation of new low moleculer weight anti-HIV compounds.
AH gene coloned from an AH producing strain was introduced into E. coli expression vector pET30 Xa/LIC to construct the AH expression plasmid. The truncated AHs were amplified by PCR using full length AH encoding gene cloned in pBluescript II SK+ as a template. Site-directed mutagenesis on pBluescript II SK+::2K3A was performed using appropriate primers. The mutant constructs were expressed in E. coli and the recombinant proteins obtained were subjected to syncytium formation assay using env-expressing HeLa cells and CD4/CXCR4expressing HeLa cells.
AH consists of highly conserved triple tandem segments. Six kinds of the truncate variations which consist of one or two segments of AH were constructed and tested for the syncytium formation inhibitory activity. It was considered that three segments of AH are essential for the syncytium formation inhibitory activity. Since the mutant AH in which two cysteine residues in a segment 2 were replaced by serine also had a similar inhibitory activity to AH, which indicates that the cysteine residues do not affect the activity of AH. Then, we identified that six amino acid residues, ^<15>D, ^<23>Y, ^<25>L, ^<28>N, ^<32>Y and ^<33>Q between LD and QXW consensus sequence of segment 1 were essential for binding to the sugar chain. Furthermore, the mutant AHs in which the LD-QXW regions of three segments were replaced with that of segment 1(Seg 1 trimer) had increased activities. These results suggest that the region between LD and QXW is important for binding to the sugar chain and the other regions are needed for suitable arrangement of each segment.

Report

(3 results)
  • 2003 Annual Research Report   Final Research Report Summary
  • 2002 Annual Research Report
  • Research Products

    (3 results)

All Other

All Publications (3 results)

  • [Publications] H.Chiba et al.: "Actinohivin, a novel anti-human immunodeficiency virus protein from an actinomycete, inhibits viral entry to cells by binding high-mannose type sugar chains of gp120."Biochem.Biophys.Res.Comm.. 316・1. 203-210 (2004)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] H.Chiba et al.: "Actinohivin, a novel anti-human immunodeficiency virus protein from an actinomycete, inhibits viral entry to cells by binding high-mannose type sugar chains of gp 120"Biochem.Biophys.Res.Comm.. 316(1). 203-210 (2004)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Chiba H, Inokoshi J, Nakashima H, Omura S, Tanaka H.: "Actinohivin, a novel anti-human immunodeficiency virus protein from an actinomycete, inhibits viral entry to cells by binding high-mannose type sugar chains of"Biochem.Biophys.Res.Commun.. 316・1. 203-210 (2004)

    • Related Report
      2003 Annual Research Report

URL: 

Published: 2002-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi